Michael King
Stock Analyst at EF Hutton
(0.79)
# 3,815
Out of 4,876 analysts
117
Total ratings
34.15%
Success rate
-16.24%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael King
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| APLM Apollomics | Maintains: Buy | $1,100 → $650 | $6.41 | +10,035.66% | 4 | Apr 1, 2024 | |
| SONN Sonnet BioTherapeutics Holdings | Assumes: Buy | $1,179 | $1.16 | +101,555.17% | 7 | Aug 23, 2023 | |
| LTRN Lantern Pharma | Reiterates: Buy | $11 | $3.14 | +250.32% | 10 | Aug 10, 2023 | |
| BMEA Biomea Fusion | Reiterates: Buy | $32 | $1.99 | +1,508.04% | 11 | Jun 26, 2023 | |
| JSPR Jasper Therapeutics | Reiterates: Buy | $69 | $5.69 | +1,103.87% | 10 | Jun 12, 2023 | |
| COEP Coeptis Therapeutics Holdings | Assumes: Buy | $200 | $8.00 | +2,400.00% | 7 | May 25, 2023 | |
| HOWL Werewolf Therapeutics | Assumes: Buy | $8.3 | $1.14 | +628.07% | 6 | May 25, 2023 | |
| REGN Regeneron Pharmaceuticals | Reiterates: Buy | $862 | $521.00 | +65.45% | 11 | May 1, 2023 | |
| EXEL Exelixis | Reiterates: Buy | $24 | $43.09 | -44.30% | 10 | Apr 28, 2023 | |
| AGEN Agenus | Reiterates: Buy | $166 | $4.91 | +3,280.86% | 8 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $42 | $8.40 | +400.00% | 5 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $304 | $318.25 | -4.48% | 2 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $123 → $116 | $9.61 | +1,107.08% | 6 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $2.60 | +296.15% | 2 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $35.48 | -32.36% | 1 | Mar 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,000 → $800 | $0.99 | +80,708.08% | 2 | Mar 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $46 | $23.38 | +96.75% | 3 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 → $96 | $33.65 | +185.29% | 6 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $0.68 | +5,198.01% | 1 | Jan 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $0.39 | +3,016.88% | 1 | Dec 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $31 | $7.34 | +322.63% | 2 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $33 → $36 | $560.04 | -93.57% | 2 | Nov 13, 2017 |
Apollomics
Apr 1, 2024
Maintains: Buy
Price Target: $1,100 → $650
Current: $6.41
Upside: +10,035.66%
Sonnet BioTherapeutics Holdings
Aug 23, 2023
Assumes: Buy
Price Target: $1,179
Current: $1.16
Upside: +101,555.17%
Lantern Pharma
Aug 10, 2023
Reiterates: Buy
Price Target: $11
Current: $3.14
Upside: +250.32%
Biomea Fusion
Jun 26, 2023
Reiterates: Buy
Price Target: $32
Current: $1.99
Upside: +1,508.04%
Jasper Therapeutics
Jun 12, 2023
Reiterates: Buy
Price Target: $69
Current: $5.69
Upside: +1,103.87%
Coeptis Therapeutics Holdings
May 25, 2023
Assumes: Buy
Price Target: $200
Current: $8.00
Upside: +2,400.00%
Werewolf Therapeutics
May 25, 2023
Assumes: Buy
Price Target: $8.3
Current: $1.14
Upside: +628.07%
Regeneron Pharmaceuticals
May 1, 2023
Reiterates: Buy
Price Target: $862
Current: $521.00
Upside: +65.45%
Exelixis
Apr 28, 2023
Reiterates: Buy
Price Target: $24
Current: $43.09
Upside: -44.30%
Agenus
Mar 28, 2023
Reiterates: Buy
Price Target: $166
Current: $4.91
Upside: +3,280.86%
Feb 24, 2023
Reiterates: Buy
Price Target: $42
Current: $8.40
Upside: +400.00%
Feb 24, 2023
Reiterates: Buy
Price Target: $304
Current: $318.25
Upside: -4.48%
Feb 24, 2023
Maintains: Buy
Price Target: $123 → $116
Current: $9.61
Upside: +1,107.08%
Dec 16, 2022
Initiates: Buy
Price Target: $10
Current: $2.60
Upside: +296.15%
Mar 23, 2022
Initiates: Buy
Price Target: $24
Current: $35.48
Upside: -32.36%
Mar 11, 2022
Maintains: Buy
Price Target: $1,000 → $800
Current: $0.99
Upside: +80,708.08%
Mar 8, 2022
Maintains: Buy
Price Target: $43 → $46
Current: $23.38
Upside: +96.75%
Mar 3, 2022
Maintains: Buy
Price Target: $98 → $96
Current: $33.65
Upside: +185.29%
Jan 10, 2022
Initiates: Buy
Price Target: $36
Current: $0.68
Upside: +5,198.01%
Dec 23, 2021
Initiates: Buy
Price Target: $12
Current: $0.39
Upside: +3,016.88%
Nov 5, 2021
Maintains: Buy
Price Target: $25 → $31
Current: $7.34
Upside: +322.63%
Nov 13, 2017
Maintains: Market Outperform
Price Target: $33 → $36
Current: $560.04
Upside: -93.57%